IL-2 induces vasopressin release from the hypothalamus and the amygdala: role of nitric oxide-mediated signaling
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
The neuropeptide arginine vasopressin (AVP) can replace the cytokine interleukin 2 (IL-2) as a T-cell mitogen for the induction of interferon gamma (IFN gamma) expression in splenic cultures. IL-2-like and IL-2 receptor immunoreactivity have been reported in different brain regions, under normal and pathophysiological conditions. Regulatory functions for IL-2 in the CNS have been suggested. In addition to the spleen, AVP might also mediate some IL-2 effects centrally. In the present study, we evaluated the effect of IL-2 on the in vitro release of AVP from the hypothalamus and amygdala. In addition, we used these release systems to study the possible involvement of NO-mediated signaling in AVP release, based on the reported detection of nitric oxide synthase (NOS) in the hypothalamus and amygdala. IL-2 rapidly stimulates AVP release in both regions, in a calcium- and dose-dependent manner. In addition, nitroprusside also induces AVP release. Norepinephrine also induces AVP release from both the hypothalamus, as well as the amygdala. The norepinephrine-induced AVP release is antagonized by phentolamine, but not by propranolol, suggesting an alpha-adrenergic receptor-mediated AVP response in both brain regions. The IL-2- and acetylcholine-induced AVP release is antagonized by Ng-methyl-L-arginine, indicating a role for NO in this AVP release. Ng-methyl-L-arginine does not affect the norepinephrine- induced AVP release. A stimulatory effect of IL-2 on hypothalamic CRF release and plasma ACTH has already been reported. Our results suggest that in addition to CRF, AVP may also mediate the IL-2 stimulation of ACTH secretion. These data further suggest that in addition to the hypothalamus, the amygdala may also play a role in the bidirectional communication between neuroendocrine and immune systems. Understanding the mode of interaction between IL-2 with AVP could clarify the pathophysiologic or toxic effects of high brain levels of IL-2.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Interleukin-1 stimulates the secretion of hypothalamic corticotropin-releasing factor
Sapolsky, R., Rivier, C., Yamamoto, G., Plotsky, P., & Vale, W. (1987) · Science · doi:10.1126/science.2821621 · Cited by 1,504 · cited 1×
“…(ACTH) release has been ascribed both to an increased release of corticotropin-releasing factor (CRF) (Berkenbosch et al., 1987, 1989; Sapolsky et al., 1987; Saphier and Ovadia, 1990; Spinedi et al., 1992) and more recently to an increased release of arginine vasopressin (AVP)…”
BackgroundCorticotropin-releasing factor-producing neurons in the rat activated by interleukin-1
Berkenbosch, F., van Oers, J., del Rey, A., Tilders, F., & Besedovsky, H. (1987) · Science · doi:10.1126/science.2443979 · Cited by 1,151 · cited 10×
“Among the AVP-containing neurons identified in the amygdala (De Vries et al., 1985), the central amygdaloid nucleus may be a possible site of interaction between norepinephrine and AVP, like described for its interaction with CRF (Ray et al., 1993), since in the late phase of hypertension there is an increased release…”
InfluentialThe vasopressinergic innervation of the brain in normal and castrated rats
DeVries, G. J., Buijs, R. M., van Leeuwen, F. W., Caffé, A. R., & Swaab, D. F. (1985) · Journal of Comparative Neurology · doi:10.1002/cne.902330206 · Cited by 522
Neuroendocrine, Sympathetic and Metabolic Responses Induced by Interleukin-1
Berkenbosch, F., de Goeij, D. E. C., del Rey, A., & Besedovsky, H. O. (2008) · Neuroendocrinology · doi:10.1159/000125283 · Cited by 162
Dunn, J. D., & Whitener, J. (2008) · Neuroendocrinology · doi:10.1159/000124442 · Cited by 154
Penetration of recombinant interleukin-2 across the blood-cerebrospinal fluid barrier
Saris, S. C., Rosenberg, S. A., Friedman, R. B., Rubin, J. T., Barba, D., & Oldfield, E. H. (1988) · Journal of Neurosurgery · doi:10.3171/jns.1988.69.1.0029 · Cited by 79
Cited by
Regulation of the Hypothalamic-Pituitary-Adrenal Axis by Cytokines: Actions and Mechanisms of Action
TURNBULL, A. V., & RIVIER, C. L. (1999) · Physiological Reviews · doi:10.1152/physrev.1999.79.1.1 · Cited by 1,297
Cytokines and cognition–the case for a head-to-toe inflammatory paradigm.
Wilson, C. J., Finch, C. E., & Cohen, H. J. (2002) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2002.50619.x · Cited by 637
Serotonin activates the hypothalamic–Pituitary–Adrenal axis via serotonin 2C receptor stimulation
Heisler, L. K., Pronchuk, N., Nonogaki, K., Zhou, L., Raber, J., Tung, L., Yeo, G. S. H., O'Rahilly, S., Colmers, W. F., Elmquist, J. K., et al. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.2584-06.2007 · Cited by 292
Self-citationPlasma nitrate plus nitrite changes during continuous intravenous infusion interleukin 2
Citterio, G., Pellegatta, F., Lucca, G., Fragasso, G., Scaglietti, U., Pini, D., Fortis, C., Tresoldi, M., & Rugarli, C. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.533 · Cited by 18
Metadata
- Authors
- Raber, J., & Bloom, F.
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 1994-10-01
- Volume
- 14
- Issue
- 10
- Pages
- 6187-6195
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- OpenAlex
- W2096690712
- Cited by
- 103
- References
- 6
- FWCI
- 3.62
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: IL-2 induces vasopressin release from the hypothalamus and the amygdala: role of nitric oxide-mediated signaling. https://app.cochat.ai/papers/10.1523/jneurosci.14-10-06187.1994
- The paper
- Raber, J., & Bloom, F. (1994). IL-2 induces vasopressin release from the hypothalamus and the amygdala: role of nitric oxide-mediated signaling. The Journal of Neuroscience. https://doi.org/10.1523/jneurosci.14-10-06187.1994
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.